“Hormone therapy” describes a family of treatments, not a single prescription. The 2020 review uses a clinical case to show why a personalized plan starts with what a patient wants to improve, then considers contraindications, underlying risks and treatment options. This reference explains that framework without supplying a prescribing regimen.
Name the symptom you want to treat
Hot flashes that interrupt work and sleep, vaginal discomfort, and concern about future fractures are different problems. They do not always call for the same treatment. Make a short list of what is most disruptive, what you have already tried and what a worthwhile improvement would look like.
Systemic treatment circulates through the body and can address vasomotor symptoms. Low-dose local vaginal treatment is directed at genitourinary symptoms and is not a treatment for hot flashes. The review discusses both; the choice depends on the symptom pattern rather than the assumption that every menopausal complaint requires systemic hormones.
Whether you have a uterus matters
Systemic estrogen without adequate endometrial protection can stimulate the lining of the uterus. Women with a uterus generally need an appropriate progestogen or another approved protective regimen alongside systemic estrogen. After hysterectomy, estrogen-alone treatment may be an option, depending on the medical history.
Tell your clinician about the type of surgery you have had, previous endometriosis, unexplained bleeding and any past problems with hormone treatment. Local low-dose vaginal estrogen has a different assessment from systemic estrogen; do not assume that the rules for one automatically apply to the other.
Route and formulation are part of the decision
Oral estrogen and transdermal estrogen reach the circulation by different routes. The review discusses transdermal options when clotting or metabolic concerns influence the decision, while acknowledging that much of the comparative evidence is observational. A patch is not a way to bypass every contraindication.
Progestogens also differ, and a schedule may be continuous or cyclic. Country-specific availability, cost, side effects, bleeding patterns and preference can all influence the plan. The paper discusses several regimens, but its 2020 descriptions are not a current list of approved products or an instruction to choose a particular dose.
If a symptom persists, the next step is reassessment rather than automatically increasing hormones. Diagnosis, adherence, side effects and other causes of the symptom may need review.
A prescription should include a follow-up plan
- Agree on the symptom goal and when to assess whether treatment is helping.
- Ask which side effects or bleeding changes should prompt contact.
- Review new diagnoses, medications and changes in risk at subsequent visits.
- Discuss alternatives if the benefit is insufficient or side effects are troublesome.
The review’s personalized-care approach is a process, not a one-time risk score. Your needs and medical history can change. A useful plan explains what you are taking, why, and how the decision will be revisited.